Skip to main content
. Author manuscript; available in PMC: 2007 Jul 24.
Published in final edited form as: Cancer Res. 2006 Nov 1;66(21):10586–10593. doi: 10.1158/0008-5472.CAN-06-1981

Table 2.

Dose response of HA22 in the treatment of intraocular lymphoma

HA22 (ng/eye) Animals Tumor development Ocular tissue damage
0 1 +
2 +
3 +
4 +
5 +
2 1 +
2 +
3 +
4 +
5 +
20 1 +
2 +
3 +
4 +
5 +
200 1
2
3
4
5
2,000 1 +/ –
2 +
3 +
4 +/ –
5 +

NOTE: Data are representative of three independent experiments.